US2001014342A1PendingUtilityA1
Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
Priority: May 5, 1994Filed: Dec 14, 2000Published: Aug 16, 2001
Est. expiryMay 5, 2014(expired)· nominal 20-yr term from priority
A61Q 1/14A61K 8/731A61Q 19/005A61P 43/00A61K 2800/75A61Q 5/02A61Q 19/004A61K 8/64A61Q 19/08A61Q 17/02A61Q 17/04
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention concerns the use of a substance P antagonist in a cosmetic composition used to treat sensitive skin. More specifically, the invention relates to a substance P antagonist used to prevent and/or combat skin irritations, desquamation, erythemas, sensations of dysesthesia/overheating, or pruritus of the skin.
Claims
exact text as granted — not AI-modified1 . Use of a substance P antagonist in a composition containing a cosmetically-acceptable medium for treatment of sensitive skin.
2 . Use according to claim 1 , wherein the substance P antagonist is chosen among the peptides and compounds containing at least one nitrogenous heterocyclic compound.
3 . Use according to claim 1 or 2 , wherein the peptide is sendide or spantide II.
4 . Use according to claim 1 or 2 , wherein the compound containing at least one nitrogenous heterocyclic compound is a derivative of 2-tricyclyl-2-aminoethane, a derivative of spirolactame, a derivative of quinuclidine, an azacyclic derivative, a derivative of aminopyrrolidine, a derivative of piperidine, an aminoazaheterocyclic compound, or a derivative of isoindole.
5 . Use according to any of the preceding claims, wherein the substance P antagonist is used in a quantity of between 0.000001 to 5% by weight of the total weight of the composition.
6 . Use according to any of the preceding claims, wherein the substance P antagonist is used in a quantity of between 0.0001 to 0.1% of the total weight of the composition.
7 . Use according to any of the preceding claims, wherein the cosmetically-acceptable medium is an aqueous or hydroalcoholic solution, a water-in-oil or oil-in-water emulsion, a microemulsion, an aqueous gel, an anhydrous gel, a serum, or a vesicular dispersion.
8 . Use according to any of the preceding claims, wherein the composition contains at least one agent chosen from among antibacterial, anti-parasitical, anti-fungal, anti-inflammatory, anti-pruriginous, anesthetic, antiviral, keratolytic, anti-free radical, anti-seborrhea, dandruff-fighting, and acne-fighting agents and/or agents modulating skin differentiation, proliferation, and/or pigmentation.
9 . Use according to the preceding claim, wherein the agent is lidocaine chlorhydrate, or a non-steroid anti-parasitical or anti-inflammatory agent.
10 . Use in a cosmetic composition of a substance P antagonist to prevent and/or combat skin irritations, desquamation, erythemas, sensations of dysesthesia, sensations of overheating, and/or pruritis of the skin.
11 . Use according to claim 10 , wherein the substance P antagonist is chosen from among peptides and compounds containing at least one nitrogenous heterocyclic compound.
12 . Use according to claim 10 or 11 , wherein the substance P antagonist is used in a quantity of between 0.000001 and 5% by weight of the total weight of the composition.
13 . Use according to any of claims 10 to 12 , wherein the substance P antagonist is used in a quantity of between 0.0001 and 0.1% by weight of the total weight of the composition.
14 . Cosmetic treatment process, wherein a composition containing a substance P antagonist in a cosmetically-acceptable medium is applied on the skin, hair, and/or mucous membranes.
15 . Process according to claim 14 , wherein the substance P antagonist is chosen from among the peptides and compounds containing at least one nitrogenous heterocyclic compound.
16 . Process according to claim 14 or 15 , wherein the substance P antagonist is used in a quantity of between 0.000001 to 5% by weight of the total weight of the composition.
17 . Process according to any of claims 14 to 16 , wherein the substance P antagonist is used in a quantity of between 0.0001 and 0.1% by weight of the total weight of the composition.
18 . Cosmetic composition containing a cosmetically-acceptable medium and at least one active ingredient producing an irritant side effect, wherein said composition contains a substance P antagonist.
19 . Cosmetic composition according to claim 18 , wherein the substance P antagonist is chosen from among the peptides and compounds containing at least one nitrogenous heterocyclic compound.
20 . Cosmetic composition according to claim 18 or 19 , wherein the substance P antagonist is used in a quantity of between 0.000001 and 5% by weight of the total weight of the composition.
21 . Cosmetic composition according to any of claims 18 to 20 , wherein the substance P antagonist is used in a quantity of between 0.0001 and 0.1% by weight of the total weight of the composition.
22 . Cosmetic composition according to any of claims 18 to 21 , wherein the active ingredient producing an irritant side effect is chosen from among α-hydroxy acids, β-hydroxy acids, α-ketonic acids, β-ketonic acids, retinoids, anthralines, anthranoids, peroxides, minoxidil, lithium salts, antimetabolites, and vitamin D and the derivatives thereof.
23 . Cosmetic composition according to any of claims 18 to 22 , wherein said cosmetic composition further contains at least one agent selected from among antibacterial, anti-parasitical, antifungal, anti-inflammatory, anti-pruriginous, anesthetic, antiviral, keratolytic, anti-free radical, anti-seborrhea, dandruff-fighting, and acne-fighting agents and/or agents modulating skin differentiation, proliferation, and/or pigmentation.
24 . Use of capsaicin for preparation of a composition intended to identify sensitive skin.Join the waitlist — get patent alerts
Track US2001014342A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.